DLEU1 and cholangiocarcinoma: YAP1 acts as a transcriptional coactivator and promotes SOX2 expression via the TEAD2 transcription factor, suggesting a DLEU1/miR-149–5p/YAP1/TEAD2/SOX2 signaling axis that contributes to CCA tumorigenesis [65].